U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556809) titled 'Exoskeleton Gait Training in Guillain-Barre Syndrome: Safety, Feasibility, Usability, and Longitudinal Outcomes' on April 14.
Brief Summary: The main objective of the study is to determine if the Atalante X exoskeleton by Wandercraft is a safe, reliable, and usable device for people with Guillain-Barre Syndrome (GBS) who are unable to walk.
The secondary objective is to assess the impact of using this device on the gait and functional recovery of this type of users (GBS).
The users undergo 20 training sessions over 6 weeks. Assessments are carried out at baseline, post-intervention, and at a 4-week follow-up after completing the ...